Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 805 JPY 0.53% Market Closed
Market Cap: 162.9B JPY
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
3Y
+35%
5Y
+40%
10Y
+26%
0
Operating Income
+0%
3Y
-
5Y
+211%
10Y
-31%
0
Net Income
+0%
3Y
-7%
5Y
+325%
10Y
+67%

Earnings Waterfall
Kissei Pharmaceutical Co Ltd

Revenue
88.3B JPY
Cost of Revenue
-44.3B JPY
Gross Profit
44.1B JPY
Operating Expenses
-38.3B JPY
Operating Income
5.8B JPY
Other Expenses
6.2B JPY
Net Income
12B JPY

Income Statement
Kissei Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025
Revenue
Interest Expense
33
32
32
31
31
30
27
26
24
24
24
23
23
22
22
23
23
23
23
23
23
23
23
23
23
23
23
23
23
23
22
21
20
19
19
18
18
18
18
20
21
Revenue
70 110
N/A
70 945
+1%
69 095
-3%
71 239
+3%
71 294
+0%
73 774
+3%
73 533
0%
72 154
-2%
71 706
-1%
71 396
0%
72 459
+1%
73 887
+2%
74 009
+0%
73 014
-1%
73 087
+0%
72 474
-1%
72 297
0%
70 545
-2%
68 180
-3%
65 594
-4%
63 234
-4%
63 196
0%
63 970
+1%
66 877
+5%
69 044
+3%
69 618
+1%
69 148
-1%
66 934
-3%
65 381
-2%
65 031
-1%
65 857
+1%
66 931
+2%
67 493
+1%
70 521
+4%
71 607
+2%
73 717
+3%
75 579
+3%
77 430
+2%
81 067
+5%
83 389
+3%
88 330
+6%
Gross Profit
Cost of Revenue
(24 063)
(24 028)
(23 194)
(23 349)
(23 582)
(25 291)
(25 403)
(25 284)
(25 076)
(24 498)
(24 811)
(25 732)
(25 878)
(26 026)
(27 064)
(26 704)
(26 735)
(26 402)
(26 084)
(27 328)
(28 340)
(30 078)
(31 664)
(34 251)
(36 321)
(37 287)
(37 059)
(35 622)
(34 143)
(33 509)
(33 899)
(34 416)
(35 118)
(36 713)
(37 115)
(38 163)
(38 238)
(38 791)
(40 629)
(41 495)
(44 265)
Gross Profit
46 047
N/A
46 917
+2%
45 901
-2%
47 890
+4%
47 712
0%
48 483
+2%
48 130
-1%
46 870
-3%
46 630
-1%
46 898
+1%
47 648
+2%
48 155
+1%
48 131
0%
46 988
-2%
46 023
-2%
45 770
-1%
45 562
0%
44 143
-3%
42 096
-5%
38 266
-9%
34 894
-9%
33 118
-5%
32 306
-2%
32 626
+1%
32 723
+0%
32 331
-1%
32 089
-1%
31 312
-2%
31 238
0%
31 522
+1%
31 958
+1%
32 515
+2%
32 375
0%
33 808
+4%
34 492
+2%
35 554
+3%
37 341
+5%
38 639
+3%
40 438
+5%
41 894
+4%
44 065
+5%
Operating Income
Operating Expenses
(37 713)
(38 692)
(37 828)
(37 077)
(37 438)
(37 367)
(38 427)
(40 103)
(38 139)
(39 914)
(39 512)
(38 949)
(38 244)
(35 930)
(36 002)
(39 366)
(39 360)
(38 864)
(37 812)
(34 295)
(33 037)
(31 689)
(30 739)
(30 318)
(31 218)
(32 166)
(32 358)
(33 291)
(32 640)
(33 087)
(34 255)
(33 131)
(33 504)
(33 434)
(32 981)
(33 011)
(33 324)
(34 097)
(36 655)
(37 803)
(38 292)
Selling, General & Administrative
(37 710)
(38 699)
(37 836)
(37 081)
(22 722)
(37 367)
(38 426)
(40 104)
(23 568)
(39 912)
(39 510)
(38 939)
(23 269)
(35 922)
(35 996)
(39 369)
(22 743)
(38 874)
(37 822)
(34 305)
(21 296)
(31 689)
(30 735)
(30 315)
(19 756)
(32 165)
(32 359)
(33 292)
(20 060)
(33 086)
(34 257)
(33 130)
(20 438)
(33 433)
(32 977)
(33 011)
(20 933)
(34 098)
(36 656)
(37 804)
(38 291)
Research & Development
0
0
0
0
0
0
0
0
(13 877)
0
0
0
(14 179)
0
0
0
(15 711)
0
0
0
(10 767)
0
0
0
(9 626)
0
0
0
(10 363)
0
0
0
(10 391)
0
0
0
(9 474)
0
0
0
0
Depreciation & Amortization
0
0
0
0
(611)
0
0
0
(695)
0
0
0
(784)
0
0
0
(909)
0
0
0
(985)
0
0
0
(1 835)
0
0
0
(2 217)
0
0
0
(2 674)
0
0
0
(2 917)
0
0
0
0
Other Operating Expenses
(3)
7
8
4
(14 105)
0
(1)
1
1
0
(2)
(10)
(12)
(8)
(6)
3
3
10
10
10
11
0
(4)
(3)
(1)
0
1
0
0
(1)
2
(1)
(1)
(1)
(4)
0
0
0
1
1
(1)
Operating Income
8 334
N/A
8 225
-1%
8 073
-2%
10 813
+34%
10 274
-5%
11 116
+8%
9 703
-13%
6 767
-30%
8 491
+25%
6 984
-18%
8 136
+16%
9 206
+13%
9 887
+7%
11 058
+12%
10 021
-9%
6 404
-36%
6 202
-3%
5 279
-15%
4 284
-19%
3 971
-7%
1 857
-53%
1 429
-23%
1 567
+10%
2 308
+47%
1 505
-35%
165
-89%
(269)
N/A
(1 979)
-636%
(1 402)
+29%
(1 565)
-12%
(2 297)
-47%
(616)
+73%
(1 129)
-83%
374
N/A
1 511
+304%
2 543
+68%
4 017
+58%
4 542
+13%
3 783
-17%
4 091
+8%
5 773
+41%
Pre-Tax Income
Interest Income Expense
1 351
1 474
1 439
989
880
1 123
1 092
1 443
1 496
1 578
1 564
1 274
1 378
1 182
1 178
1 130
1 054
1 030
1 078
2 085
3 440
3 398
6 399
6 590
5 203
8 847
9 073
9 374
18 103
15 912
15 503
16 922
14 636
14 920
15 013
13 210
10 010
11 215
10 498
13 718
13 226
Non-Reccuring Items
706
533
343
139
(58)
(339)
(236)
133
65
423
681
680
387
199
(388)
(841)
(226)
(428)
(129)
136
(802)
(573)
(664)
(639)
646
426
118
(67)
(440)
(284)
89
280
66
511
249
84
305
(211)
(145)
(2 856)
(3 205)
Gain/Loss on Disposition of Assets
(103)
(115)
(103)
(116)
0
(10)
(12)
1
(13)
(30)
(34)
(34)
(37)
(35)
(25)
(26)
(2)
23
11
11
(35)
(60)
(55)
0
(10)
(32)
(24)
(24)
(35)
0
(14)
(14)
63
63
61
46
80
43
(56)
(59)
(215)
Total Other Income
178
191
(259)
149
40
34
272
58
77
91
92
57
82
79
84
84
93
95
104
124
170
176
224
148
132
172
140
315
281
312
371
212
44
20
(70)
(93)
37
32
26
29
31
Pre-Tax Income
10 466
N/A
10 308
-2%
9 493
-8%
11 974
+26%
11 136
-7%
11 924
+7%
10 819
-9%
8 402
-22%
10 116
+20%
9 046
-11%
10 439
+15%
11 183
+7%
11 697
+5%
12 483
+7%
10 870
-13%
6 751
-38%
7 121
+5%
5 999
-16%
5 348
-11%
6 327
+18%
4 630
-27%
4 370
-6%
7 471
+71%
8 407
+13%
7 476
-11%
9 578
+28%
9 038
-6%
7 619
-16%
16 507
+117%
14 375
-13%
13 652
-5%
16 784
+23%
13 680
-18%
15 888
+16%
16 764
+6%
15 790
-6%
14 449
-8%
15 621
+8%
14 106
-10%
14 923
+6%
15 610
+5%
Net Income
Tax Provision
(3 277)
(3 126)
(2 856)
(3 424)
(2 940)
(3 159)
(2 675)
(1 960)
(2 351)
(2 009)
(2 281)
(2 404)
(2 598)
(2 750)
(2 722)
(1 437)
(1 586)
(1 186)
(982)
(1 493)
(1 741)
(1 795)
(2 361)
(2 622)
(2 098)
(2 231)
(2 346)
(1 828)
(3 475)
(3 360)
(2 966)
(3 911)
(3 046)
(3 586)
(3 742)
(3 448)
(3 159)
(3 550)
(3 320)
(3 230)
(3 634)
Income from Continuing Operations
7 189
7 182
6 637
8 550
8 196
8 765
8 144
6 442
7 765
7 037
8 158
8 779
9 099
9 733
8 148
5 314
5 535
4 813
4 366
4 834
2 889
2 575
5 110
5 785
5 378
7 347
6 692
5 791
13 032
11 015
10 686
12 873
10 634
12 302
13 022
12 342
11 290
12 071
10 786
11 693
11 976
Income to Minority Interest
(23)
(22)
(28)
(28)
(30)
(30)
(35)
(40)
(39)
(42)
(41)
(45)
(52)
(49)
(44)
(49)
(54)
(59)
(71)
(79)
(71)
(44)
(47)
(71)
(93)
(143)
(138)
(127)
(110)
(102)
(103)
(103)
(105)
(142)
(141)
(143)
(128)
(70)
(52)
(27)
(14)
Net Income (Common)
7 165
N/A
7 161
0%
6 608
-8%
8 521
+29%
8 165
-4%
8 734
+7%
8 108
-7%
6 401
-21%
7 726
+21%
6 993
-9%
8 116
+16%
8 735
+8%
9 045
+4%
9 685
+7%
8 102
-16%
5 263
-35%
5 481
+4%
4 752
-13%
4 294
-10%
4 753
+11%
2 817
-41%
2 530
-10%
5 063
+100%
5 715
+13%
5 285
-8%
7 204
+36%
6 555
-9%
5 664
-14%
12 921
+128%
10 912
-16%
10 581
-3%
12 769
+21%
10 528
-18%
12 158
+15%
12 880
+6%
12 198
-5%
11 160
-9%
12 001
+8%
10 731
-11%
11 663
+9%
11 961
+3%
EPS (Diluted)
146.22
N/A
146.14
0%
134.85
-8%
173.89
+29%
166.88
-4%
178.24
+7%
165.46
-7%
130.63
-21%
158.73
+22%
145.68
-8%
169.08
+16%
181.97
+8%
188.24
+3%
206.06
+9%
172.38
-16%
112.65
-35%
117.33
+4%
101.72
-13%
91.92
-10%
101.74
+11%
60.3
-41%
54.16
-10%
108.38
+100%
122.33
+13%
113.25
-7%
156.21
+38%
142.14
-9%
122.82
-14%
280.19
+128%
236.63
-16%
229.45
-3%
276.89
+21%
228.3
-18%
264.18
+16%
281.08
+6%
271.49
-3%
246.58
-9%
271.48
+10%
242.75
-11%
269.52
+11%
274.2
+2%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 255,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.